PIGC expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.228200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.441800E-01
Normal-vs-Stage2
6.973400E-01
Normal-vs-Stage3
2.732400E-01
Normal-vs-Stage4
4.023200E-01
Stage1-vs-Stage2
6.227200E-01
Stage1-vs-Stage3
5.335000E-01
Stage1-vs-Stage4
1.199570E-01
Stage2-vs-Stage3
2.607800E-01
Stage2-vs-Stage4
2.708600E-01
Stage3-vs-Stage4
1.338220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.352600E-01
Normal-vs-AfricanAmerican
5.634600E-01
Normal-vs-Asian
6.686800E-01
Caucasian-vs-AfricanAmerican
8.322300E-02
Caucasian-vs-Asian
8.809500E-02
AfricanAmerican-vs-Asian
7.162400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.392200E-01
Normal-vs-Female
7.003800E-01
Male-vs-Female
8.169600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.234800E-01
Normal-vs-Age(41-60Yrs)
9.107800E-01
Normal-vs-Age(61-80Yrs)
6.202800E-01
Normal-vs-Age(81-100Yrs)
9.424400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.395030E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.722400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.292000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.407840E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.137200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.740000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.129600E-01
Normal-vs-Daily Drinker
2.519800E-01
Normal-vs-Weekly Drinker
9.086200E-01
Normal-vs-Occasional Drinker
8.564600E-01
Normal-vs-Social Drinker
3.880800E-01
Non Drinker-vs-Daily Drinker
1.272420E-01
Non Drinker-vs-Weekly Drinker
6.639800E-01
Non Drinker-vs-Occasional Drinker
7.511800E-01
Non Drinker-vs-Social Drinker
6.709200E-01
Daily Drinker-vs-Weekly Drinker
9.662400E-02
Daily Drinker-vs-Occasional Drinker
1.088380E-01
Daily Drinker-vs-Social Drinker
2.361200E-01
Weekly Drinker-vs-Occasional Drinker
9.062800E-01
Weekly Drinker-vs-Social Drinker
4.496400E-01
Occasional Drinker-vs-Social Drinker
5.063200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.952500E-02
Normal-vs-Grade 2
2.421100E-03
Normal-vs-Grade 3
1.720070E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.768600E-01
Grade 1-vs-Grade 3
3.103400E-01
Grade 1-vs-Grade 4
6.952500E-02
Grade 2-vs-Grade 3
5.769200E-01
Grade 2-vs-Grade 4
2.421100E-03
Grade 3-vs-Grade 4
1.720070E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.723400E-01
Normal-vs-NonDiabetic
8.487800E-01
Diabetic-vs-NonDiabetic
3.463000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.507000E-01
Normal-vs-NoPancreatitis
7.014000E-01
Pancreatitis-vs-NoPancreatitis
7.451000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.531600E-01
Normal-vs-N1
7.153000E-01
N0-vs-N1
5.451200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.486200E-01
Normal-vs-TP53-NonMutant
7.750400E-01
TP53-Mutant-vs-TP53-NonMutant
4.427700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
